Clinical efficacy of Leuprolide acetate and combined treatment with estramustine for advanced prostate cancer

Japanese Journal of Urology

Volumn 92, Issue 7, 2001, Pages 682-693

  Saito, S ^a   Nakashima, J ^a   Nakajima, Y ^a   Ikeuchi, K ^a   Shibayama, T ^a   Nagakura, K ^a   Naide, Y ^a   Hayakawa, M ^a   Ogawa, Y ^a   Hata, M ^a   Nakazono, M ^a   Hasegawa, S ^a   Oda, T ^a   Kimura, S ^a,a   Nakamura, S ^a   Matsunaga, J ^a   Fujioka, T ^a   Tanoguchi, H ^a   Aoki, S ^a   Yamamoto, Y ^a   Izawa, A ^a   Suzuki, K ^a   Tazaki, H ^a   Murai, M ^a   more..

^a NONE

Author keywords

Estramustine phosphate; Leuprolide acetate; Prostate cancer

Indexed keywords

ESTRAMUSTINE PHOSPHATE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD LEVEL; BODY WEIGHT; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICTURITION; PROSTATE CANCER; TREATMENT OUTCOME;

EID: 0035206587     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.92.682     Document Type: Article

References (20)

1. Studies on prostate cancer
2. Fantors in the prognosis of carcinoma of the prostate: A cooperative study
3. Trends in patterns of care for prostatic cancer, 1974-1983: Results of surveys by the American College of Surgeons
4. Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: A randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate
5. Hormonal therapies in prostatic cancer
6. A controlled trial of leuprolide with and without flutamide in prostate carcinoma
7. Estramustine phosphate: Metabolic aspects related to its action in prostate cancer
8. Management of occult prostatic carcinoma
9. Clinical efficacy and safety of a new leuprorelin acetate fepot formulation in patients with advanced prostatic cancer
10. Leuprolide versus diethylstibestrol for metastatic prostate cancer
11. 2 adenocarcinoma of prostate
12. Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: Clinical response and hormonal mechanisms